Axa’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-101,816
| Closed | -$2.73M | – | 1250 |
|
|
2022
Q1 | $2.73M | Buy |
101,816
+1
| +0% | +$27 | 0.01% | 777 |
|
|
2021
Q4 | $4.86M | Buy |
101,815
+1,217
| +1% | +$58.1K | 0.01% | 671 |
|
|
2021
Q3 | $6.68M | Buy |
100,598
+3,702
| +4% | +$246K | 0.02% | 604 |
|
|
2021
Q2 | $7.56M | Buy |
96,896
+15,390
| +19% | +$1.2M | 0.02% | 590 |
|
|
2021
Q1 | $7.71M | Buy |
81,506
+1,510
| +2% | +$143K | 0.02% | 578 |
|
|
2020
Q4 | $9.75M | Sell |
79,996
-11,470
| -13% | -$1.4M | 0.03% | 530 |
|
|
2020
Q3 | $7.99M | Sell |
91,466
-40,151
| -31% | -$3.51M | 0.03% | 523 |
|
|
2020
Q2 | $8.5M | Sell |
131,617
-12,809
| -9% | -$827K | 0.03% | 474 |
|
|
2020
Q1 | $6.45M | Sell |
144,426
-8,143
| -5% | -$364K | 0.03% | 458 |
|
|
2019
Q4 | $9.5M | Buy |
+152,569
| New | +$9.5M | 0.04% | 461 |
|